Bausch + Lomb Corporation (BLCO) is a publicly traded Healthcare sector company. As of October 12, 2026, BLCO trades at $16.99 with a market cap of $6.18B and a P/E ratio of -35.72. BLCO moved -1.79% today. Year to date, BLCO is +1.29%; over the trailing twelve months it is +19.97%. Its 52-week range spans $10.45 to $18.92. Analyst consensus is buy with an average price target of $20.60. Rallies surfaces BLCO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BLCO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $16.99 |
| Market Cap | $6.18B |
| P/E Ratio | -35.72 |
| EPS | $-0.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.92 |
| 52-Week Low | $10.45 |
| Volume | 2.60K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.32B |
| Net Income | $-163.00M |
| Gross Margin | 0.00% |
12 analysts cover BLCO: 0 strong buy, 6 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.60.